Tag Archives: PrEP

SPECIAL REPORT | THE INDEPENDENT | Philanthropist Bill Gates, the founder and co-chair of the Bill and Melinda Gates Foundation says more lives can be saved from HIV if modern HIV prevention tools can be spread out. The Bill and Melinda Gates Foundation has been one of the biggest funder to …

Kampala, Uganda | THE INDEPENDENT | A new HIV prevention study has found that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected women from contracting HIV. Findings of the the PURPOSE 1 HIV prevention study among adolescent girls and young women in South Africa and Uganda was released …

Virus still a burden among young people Kampala, Uganda | PATRICIA AKANKWATSA | Uganda Network of AIDS Services Organisation (UNASO) wants the fight against HIV/AIDS in Uganda to focus on encourage health-seeking behavior as the disease continues to spread; especially among young people. While presenting the National HIV/Aids Report, Dr …

Kampala, Uganda | THE INDEPENDENT | The World Health Organization-WHO on Thursday released new guidelines giving countries a green light to use long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV. The guidelines that were released ahead of the annual International AIDS Conference will support countries as they plan for …

Study shows why it matters to young African women Kampala, Uganda | RONALD MUSOKE | A new HIV prevention study has found that when young women have access to and experience with two biomedical prevention options, the Dapivirine Vaginal Ring (DVR) and Truvada, an oral pre-exposure prophylaxis (PrEP) drug, almost …

Kampala, Uganda | THE INDEPENDENT | Researchers will in December enroll the first participants in a clinical trial in which they are testing the effectiveness of a new HIV drug, Lenacapavir in protecting people against the virus. This study will be conducted in four districts of Mityana, Masaka, Hoima and Kalangala …

Masaka, Uganda | THE INDEPENDENT | Researchers are studying the effectiveness of a daily Pre-Exposure Prophylaxis (PrEP) drug Descovy in their HIV vaccine study that was launched recently in Masaka district. Dr Eugene Ruzagira, a member of the team of researchers told a news conference organized by the Health Journalists Network …

Kampala, Uganda | THE INDEPENDENT | Researchers at Makerere University – John Hopkins Research Collaboration (MU-JHU) are embarking on a new study to establish the effectiveness of using the new HIV drug, Islatravir in HIV prevention as a Pre-exposure Prophylaxis (PrEP). Dr Gatti Brenda Mirembe, the principal investigator on the study …

Kampala, Uganda | THE INDEPENDENT | A new HIV Pre-exposure Prophylaxis (PrEP) study is underway to establish whether a six months-long injectable drug, Lenacapavir (LEN), and oral drug Descovy can protect HIV negative women and girls from acquiring the virus. The two-part study is being done by a team of researchers …

Kampala, Uganda | THE INDEPENDENT | Uganda has been listed among the first seven countries that will benefit from the roll out of the vaginal ring used in prevention against HIV, the International Partnership for Microbicides (IPM) has revealed. IPM’s external relations director Dr. Leonard Solai told journalists that other …